Cephalon Purchases Majority Stake In Australian Biotech Arana, Clearing Way For Full-scale Acquisition

PERTH, Australia - Through ongoing buying of shares in the target company, Cephalon International Holdings has achieved a controlling 50 percent-plus interest in Australian biotech Arana. Cephalon's offer to acquire Arana is now "free from all outstanding conditions," Cephalon announced May 20